Overview
Accessory mitral valve tissue (AMVT) is a rare congenital cardiac anomaly in which additional tissue, distinct from the normal mitral valve leaflets, is present in the left ventricular outflow tract (LVOT) or attached to the mitral valve apparatus. This accessory tissue may be a membrane, a fibrous strand, or a mobile mass that can cause obstruction of the LVOT, leading to subaortic stenosis. It is classified under congenital malformations of the mitral valve (ICD-10: Q23.8). AMVT may occur as an isolated finding or in association with other congenital heart defects such as ventricular septal defect, subaortic membrane, or other left-sided obstructive lesions. Clinically, many patients with accessory mitral valve tissue are asymptomatic and the condition is discovered incidentally during echocardiography performed for other reasons. When symptomatic, patients may present with exertional dyspnea, syncope, chest pain, or heart murmur due to LVOT obstruction. In some cases, the accessory tissue can also cause mitral regurgitation. The severity of symptoms depends on the degree of outflow tract obstruction and the mobility and size of the accessory tissue. Diagnosis is typically made by transthoracic or transesophageal echocardiography, which can delineate the morphology and hemodynamic significance of the accessory tissue. Treatment depends on the clinical significance of the anomaly. Asymptomatic patients with no significant LVOT obstruction may be managed conservatively with regular echocardiographic surveillance. Surgical excision of the accessory tissue is recommended for patients with significant LVOT obstruction (typically a mean gradient greater than 30-50 mmHg), progressive symptoms, or associated complications such as endocarditis or embolism. Surgical outcomes are generally favorable, with low recurrence rates, though long-term follow-up is recommended to monitor for recurrence of obstruction or development of mitral valve dysfunction.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Accessory mitral valve tissue.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Accessory mitral valve tissue at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Accessory mitral valve tissue.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Accessory mitral valve tissue.
Community
No community posts yet. Be the first to share your experience with Accessory mitral valve tissue.
Start the conversation →Latest news about Accessory mitral valve tissue
No recent news articles for Accessory mitral valve tissue.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Accessory mitral valve tissue
What is Accessory mitral valve tissue?
Accessory mitral valve tissue (AMVT) is a rare congenital cardiac anomaly in which additional tissue, distinct from the normal mitral valve leaflets, is present in the left ventricular outflow tract (LVOT) or attached to the mitral valve apparatus. This accessory tissue may be a membrane, a fibrous strand, or a mobile mass that can cause obstruction of the LVOT, leading to subaortic stenosis. It is classified under congenital malformations of the mitral valve (ICD-10: Q23.8). AMVT may occur as an isolated finding or in association with other congenital heart defects such as ventricular septal
How is Accessory mitral valve tissue inherited?
Accessory mitral valve tissue follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.